Prolylcarboxypeptidase regulates food intake by inactivating α-MSH in rodents
Open Access
- 20 July 2009
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 119 (8), 2291-2303
- https://doi.org/10.1172/jci37209
Abstract
The anorexigenic neuromodulator α-melanocyte–stimulating hormone (α-MSH; referred to here as α-MSH1–13) undergoes extensive posttranslational processing, and its in vivo activity is short lived due to rapid inactivation. The enzymatic control of α-MSH1–13 maturation and inactivation is incompletely understood. Here we have provided insight into α-MSH1–13 inactivation through the generation and analysis of a subcongenic mouse strain with reduced body fat compared with controls. Using positional cloning, we identified a maximum of 6 coding genes, including that encoding prolylcarboxypeptidase (PRCP), in the donor region. Real-time PCR revealed a marked genotype effect on Prcp mRNA expression in brain tissue. Biochemical studies using recombinant PRCP demonstrated that PRCP removes the C-terminal amino acid of α-MSH1–13, producing α-MSH1–12, which is not neuroactive. We found that Prcp was expressed in the hypothalamus in neuronal populations that send efferents to areas where α-MSH1–13 is released from axon terminals. The inhibition of PRCP activity by small molecule protease inhibitors administered peripherally or centrally decreased food intake in both wild-type and obese mice. Furthermore, Prcp-null mice had elevated levels of α-MSH1–13 in the hypothalamus and were leaner and shorter than the wild-type controls on a regular chow diet; they were also resistant to high-fat diet–induced obesity. Our results suggest that PRCP is an important component of melanocortin signaling and weight maintenance via control of active α-MSH1–13 levels.This publication has 33 references indexed in Scilit:
- Pnlip encoding pancreatic lipase is possible candidate for obesity QTL in the OLETF ratBiochemical and Biophysical Research Communications, 2005
- MUTATED G‐PROTEIN‐COUPLED RECEPTOR GPR10 IS RESPONSIBLE FOR THE HYPERPHAGIA/DYSLIPIDAEMIA/OBESITY LOCUS OF Dmo1 IN THE OLETF RATClinical and Experimental Pharmacology and Physiology, 2005
- Microarray gene expression analysis of theFob3bobesity QTL identifies positional candidate geneSqleand perturbed cholesterol and glycolysis pathwaysPhysiological Genomics, 2005
- Recombinant prolylcarboxypeptidase activates plasma prekallikreinBlood, 2004
- Evidence for substantial effect modification by gender in a large-scale genetic association study of the metabolic syndrome among coronary heart disease patientsHuman Genetics, 2003
- Multiple linked mouse chromosome 7 loci influence body fat massInternational Journal of Obesity, 2003
- Identification and Characterization of Prolylcarboxypeptidase as an Endothelial Cell Prekallikrein ActivatorOnline Journal of Public Health Informatics, 2002
- Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 geneNature Genetics, 1997
- Role of melanocortinergic neurons in feeding and the agouti obesity syndromeNature, 1997
- Neomorphic agouti mutations in obese yellow miceNature Genetics, 1994